Information for healthcare professionals - Targeted deployment of COVID-19 medicines for non-hospitalised patients

Changes have been made to the UK-wide clinical commissioning policy to reflect both the current understanding on the likely impact of the Omicron variant on the efficacy of the combination nMAB casiri
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news